医疗保险受益者中社会人口学因素与筛查性CT结肠成像的使用
该回顾性研究利用2011年至2020年CMS 5%样本数据,分析45-85岁医疗保险按服务收费受益者中筛查性CT结肠成像(CTC)及其他结直肠癌筛查方式的使用与收入、种族和民族、城乡居住地的关联。结果显示筛查性CTC与高收入的关联(OR 5.73)远大于其他筛查方式或诊断性CTC;西班牙裔与非西班牙裔黑人使用筛查性CTC的OR分别为1.00和1.08;小城镇或农村居民OR为0.51和0.65。
要点
- 高收入社区(≥10万美元)人群接受筛查性CTC的OR为5.73,远高于其他筛查方式。
- 西班牙裔与非西班牙裔黑人使用筛查性CTC的OR分别为1.00和1.08,与非西班牙裔白人相近。
- 小城镇或农村居民使用筛查性CTC的OR分别为0.51和0.65,低于大都市居民。
核心结论
- 筛查性CTC与收入的关联显著大于其他结直肠癌筛查方式或诊断性CTC;医疗保险不覆盖筛查性CTC可能降低低收入受益者对筛查指南的依从性。
研究设计与样本
- 回顾性研究,使用2011年1月1日至2020年12月31日CMS可识别研究文件(覆盖5%医疗保险按服务收费受益者),纳入45-85岁、排除高结直肠癌风险个体,共12,273,363受益年、2,436,849名唯一受益者;采用多变量logistic回归模型,控制性别、年龄、Charlson合并症指数、美国人口普查区域、筛查年份及相关疾病和操作。
诊断标准与关键数值
- 与社区人均收入低于25,000美元者相比,收入10万美元及以上者接受筛查性CTC的OR为5.73,光学结肠镜OR为1.36,乙状结肠镜OR为1.03,愈创木脂粪便隐血试验或粪便免疫化学试验OR为1.50,粪便DNA检测OR为1.43,诊断性CTC OR为2.00。
- 与非西班牙裔白人相比,西班牙裔个体接受筛查性CTC的OR为1.00,非西班牙裔黑人OR为1.08。
- 与大都市区居民相比,小城镇区居民接受筛查性CTC的OR为0.51,小城镇或农村地区居民OR为0.65。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Approximately one-third of the eligible U.S. population have not undergone guideline-compliant colorectal cancer (CRC) screening. Guidelines recognize various screening strategies to increase adherence. CMS provides coverage for all recommended screening tests except CT colonography (CTC). OBJECTIVE. The purpose of this study was to compare CTC and other CRC screening tests in terms of associations of utilization with income, race and ethnicity, and urbanicity in Medicare fee-for-service beneficiaries. METHODS. This retrospective study used CMS Research Identifiable Files from January 1, 2011, through December 31, 2020. These files contain claims information for 5% of Medicare fee-for-service beneficiaries. Data were extracted for individuals 45-85 years old, and individuals with high CRC risk were excluded. Multivariable logistic regression models were constructed to determine the likelihood of undergoing CRC screening tests (as well as of undergoing diagnostic CTC, a CMS-covered test with similar physical access as screening CTC) as a function of income, race and ethnicity, and urbanicity while controlling for sex, age, Charlson comorbidity index, U.S. census region, screening year, and related conditions and procedures. RESULTS. For 12,273,363 beneficiary years (mean age, 70.5 ± 8.2 [SD] years; 2,436,849 unique beneficiaries: 6,774,837 female beneficiaries, 5,498,526 male beneficiaries), there were 785,103 CRC screenings events, including 645 for screening CTC. Compared with individuals living in communities with per capita income of less than US$25,000, individuals in communities with income of US$100,000 or more had OR for undergoing screening CTC of 5.73, optical colonoscopy (OC) of 1.36, sigmoidoscopy of 1.03, guaiac fecal occult blood test or fecal immunochemical test of 1.50, stool DNA of 1.43, and diagnostic CTC of 2.00. The OR for undergoing screening CTC was 1.00 for Hispanic individuals and 1.08 for non-Hispanic Black individuals compared with non-Hispanic White individuals. Compared with the OR for undergoing screening CTC for residents of metropolitan areas, the OR was 0.51 for residents of micropolitan areas and 0.65 for residents of small or rural areas. CONCLUSION. The association with income was substantially larger for screening CTC than for other CRC screening tests or for diagnostic CTC. CLINICAL IMPACT. Medicare's noncoverage for screening CTC may contribute to lower adherence with CRC screening guidelines for lower-income beneficiaries. Medicare coverage of CTC could reduce income-based disparities for individuals avoiding OC owing to invasiveness, need for anesthesia, or complication risk.
引用
- Christensen EW, Sanelli PC, Rula EY, et al. Sociodemographic Factors and Screening CT Colonography Use Among Medicare Beneficiaries. AJR Am J Roentgenol. 2023. PMID: 37466190. doi:10.2214/AJR.23.29703
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。